The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and … Bionano Genomics, Inc. (Nasdaq:BNGO) announced today that company management will present virtually at the Cowen 41 Annual Health Care Conference. Contacts Company Contact: R. Erik Holmlin, CEO Bionano Genomics, Inc. +1 (858) 888-7600 eholmlin@bionanogenomics.com Investor Relations Contact: Ashley … The AP news staff was not involved in its creation. Press release content from Globe Newswire. 4 Bionano Genomics… There can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. 07:38 AM ET. Bionano also expects to grant … --Bionano Genomics, Inc. announced today that company management will present virtually at the Cowen 41 st Annual Health Care Conference. SIGN UP. Bionano’s Saphyr system is a research … SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at … The AP news staff was not involved in its creation. SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that its Saphyr system is being piloted by the University Health Network's (UHN) Laboratory Medicine Program (LMP) in Toronto. ET The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. SAN DIEGO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that its Saphyr system is being piloted by the University Health Network’s (UHN) Laboratory Medicine Program (LMP) in Toronto. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Press release content from Globe Newswire. Press release content from Globe Newswire. Bionano Genomics Inc. [NASDAQ: BNGO] gained 8.67% on the last trading session, reaching $7.77 price per share at the time. The company report on March 3, 2021 that Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr.. Get the hottest stocks to trade every day before the market opens 100% free. Bionano Genomics, Inc. (NASDAQ: BNGO) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. Investors are always looking for stocks that are poised to beat at earnings season and Bionano Genomics, Inc. BNGO may be one such company. All News Headlines and Company Releases. SC 13G/A Bionano Genomics, Inc (0001411690) (Subject) Feb 08,2021 17:42. Press Release Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement Published: Jan. 13, 2021 at 4:01 p.m. Bionano Genomics stock price target raised to $14 from $2 at Maxim Group MarketWatch. Such forward-looking statements include, without limitation, statements about Bionano’s expectations regarding the completion, timing and gross proceeds of the public offering. Bionano Genomics, Inc., which has a market valuation of $1.25 Billion, is expected to release its quarterly earnings report in Apr 2021. Bionano Genomics’ Early-Access Customers to Present Groundbreaking Genome Assembly Data Using Bionano’s New Labeling Technology at PAG XXVI Conference January 12, 2018 DuPont Pioneer discussed building research-ready reference genomes with Bionano Genomics’ Saphyr system at the 5th Plant Genomics & Gene Editing Congress in Philadelphia, PA LOG IN. SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it plans to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. SAN DIEGO, June 08, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the United States Patent and Trademark Office will issue US Patent No. --BIONANO GENOMICS, INC., announced today the pricing of its previously announced underwritten public offering of 33,333,350 shares of its common … NEW YORK, March 10, 2021 /PRNewswire via COMTEX/ -- NEW YORK, March 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, GME, JNJ, BNGO, and SINT. Thinking about buying stock in OpGen, GameStop, Johnson & Johnson, BioNano Genomics, or SINTX Technologies? Wednesday, Jan 20, 2021. The AP news staff was not involved in its creation. Press release content from Globe Newswire. Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades. Press Release Bionano Genomics Announces Pricing of $88.5 Million Underwritten Public Offering of Common Stock Published: Jan. 8, 2021 at 8:45 a.m. Press Release Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock Published: Jan. 19, 2021 at 4:25 p.m. The firm … Releases. SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it plans to offer and sell, subject to market and … It is understandable that investor optimism is growing ahead of the company’s current quarter results. News provided by. Find the latest Bionano Genomics (BNGO) press releases from Webull to help you in your trading and investing BNGO decisions. Contacts Company Contact: Erik Holmlin, CEO Bionano Genomics, Inc. +1 (858) 888-7610 eholmlin@bionanogenomics.com Investor Relations Contact: Ashley … Bionano Genomics' stock rally result of awareness push in 2019 and 2020 about its genomic technology: analyst MarketWatch. 09:48 AM ET . News Headlines for Bionano Genomics Inc. Friday, Jan 22, 2021. ET SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast … Bionano Genomics to Report Fourth Quarter and Year End 2020 Financial Results and Host a ... Bionano Genomics March 9, 2021 GMT. ET HOME MARKET TRADE PRICING DOWNLOAD HELP. Press release content from Globe Newswire. UPDATE: Bionano Genomics … The AP news staff was not involved in its creation. CONTACTS Company Contact: Erik Holmlin, CEO Bionano Genomics, Inc. +1 (858) 888-7610 eholmlin@bionanogenomics.com Investor Relations Contact: Ashley … Find the latest press releases from Bionano Genomics, Inc. Common Stock (BNGO) at Nasdaq.com. BNGO--0.00% --All; Financials; Insiders; 8-K Bionano Genomics, Inc (0001411690) (Filer) Feb 19,2021 16:05. About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. The AP news staff was not involved in its creation. SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the release of version 1.2 of its Compute On Demand (COD) … Bionano Genomics will not be reviewing or updating the material that is contained in these items after the date thereof. InvestorsObserver Mar 10, … The information contained therein is only accurate as of the date thereof. You are about to review presentations, reports and/or filings of Bionano Genomics, that contain time-sensitive information. SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Praxis Genomics, LLC received DEX Z-codes from Palmetto MolDX for its entire testing menu of laboratory developed tests (LDTs) based on Saphyr.